Nas dissertation presentation dr sue
Published on: Mar 3, 2016
Transcripts - Nas dissertation presentation dr sue
Nursing Clinical Leadership Role in
Facilitating Successful Outcomes of NAS
Neonates and Mothers During Postpartum
Period and at Discharge
A Work in Progress…
Abuse of prescription pain relievers by pregnant women can result in a number
of problems in newborns, referred to as neonatal abstinence syndrome (NAS).
This condition occurs in newborns due to sudden discontinuation from
intrauterine exposure to opioids such as oxycodone, Demerol, and other
NAS is characterized by tremors, irritability and restlessness hypertonicity,
tremors, excessive high-pitched cry, which interferes with maternal-newborn
bonding and interactions. This may lead to maternal lack of sensitivity to infant
cues, and may result in “Maternal Postpartum Role Collapse”
Unfortunately, newborns with NAS are sometimes discharged home—
unrecognized at risk of complications that stems from poor interaction, abuse,
Assumption: That the maternal cognitive state due to
withdrawal from substance abuse has a negative effect
on interactions of mother and neonates going through
withdrawal. Babies born to moms who depend on drugs
frequently have additional complications that require
specialized treatments and care; during postpartum and
Purpose of the Study
This research sets out to examine the effects of opioids
withdrawal symptoms on early postpartum bonding, and
interactions between mothers and neonates.
To identify standards of nursing practice needed to manage
and meet mothers’ and neonates’ postpartum substance
To measure the efficacy of available discharge plans and
teaching and the impact of a successful transition of
substance-exposed neonates and their families.
Demonstrate ways that leadership can set standards of
practice in postpartum units in order to enhance interaction
of new mothers with their drug-exposed neonates.
Purpose of the Study Contd.
Effects of opioids withdrawal on postpartum bonding
and early interaction—create a clinical leadership
role at the point of care, by identifying themes that
would facilitate successful outcomes and discharge
of this population.
What is nursing leadership’s role in enhancement of
successful outcomes of NAS neonates and mothers during
postpartum period and at discharge?
How can nurses help mothers manage postpartum
substance withdrawal in order to enhance interaction with
their drug-exposed neonates?
What are the standards of practice for substance-exposed
neonates and their families?